glp 1 idiopathic intracranial hypertension Management of IIH. The treatment of IIH focuses on vision preservation Current Understanding of the Pathophysiology

For the more than 48 million Americans with substance use disorders, including a disproportionate share of veterans, GLP-1 drugs are not yet an approved addiction treatment

For the 40% of American adults with obesity, glucagon-like peptide-1 receptor agonists, or GLP-1 drugs, may offer hopebut the cost can put them out of reach for many patients

Here's what clinicians should know.

Sure, muscle shapes our physique, but it's not only about looking toned and fitits essential for our metabolism, long-term health, and staying strong as we age

As their popularity continues to rise, employers face a unique set of opportunities and challenges, particularly regarding cost management and employee wellbeing

For practitioners, this changes the way we think about intervention: Less guesswork More precision Better adherence driven by satiety Stronger, more predictable outcomes Science